chevron_leftBack
As of 24 April 2025, ClearPoint Neuro, Inc. has a market cap of $366.13M USD, ranking #13767 globally and #2486 in the United States. It ranks #1361 in the Healthcare sector, and #148 in the Medical Devices industry.
Key Stats
Market Cap
$366.13MUSD
Enterprise Value
$349.59MUSD
Revenue (TTM)
$31.39MUSD
EBITDA (TTM)
-$18.77MUSD
Net Income (TTM)
-$18.91MUSD
EBITDA Margin
-60%
Profit Margin
-60%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Joseph Burnett
open_in_new
Employees
115
Founded
1998
Website
clearpointneuro.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 3.5% | 15% | -1% | -26% | 3.6% | 140% |
Upcoming Earnings
Earnings Date
Tue, May 6
Earnings Time
bedtime
After Close
EPS Estimate
-$0.1600
Revenue Estimate
$8.21M
7.5% yoy
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
CLPT
ClearPoint Neuro Inc
ISIN: US18507C1036
Shares Out.:
Shares Outstanding:
27.98M1
Shares Float:
24.141M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
13.25 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
